Live Breaking News & Updates on Hematologic Oncology

Stay updated with breaking news from Hematologic oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Carraway on the Importance of NGS in Relapsed/Refractory AML

Hetty E. Carraway, MD, MBA, discusses the importance of testing for targetable mutations in patients with relapsed/refractory acute myeloid leukemia. ....

Division Of Hematologic Oncology , Oncology Program , Enterprise Development , Department Of Medicine , Case Comprehensive Cancer Center , Taussig Cancer Institute , School Of Medicine , Cleveland Clinic Lerner College , Case Western Reserve University , Immune Oncology Program , Hematologic Oncology , Blood Disorders , Cleveland Clinic ,

Physician Advocate: Healing During the AIDS Epidemic

Physician Advocate: Healing During the AIDS Epidemic
dartmouth.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dartmouth.edu Daily Mail and Mail on Sunday newspapers.

Columbia University , New York , United States , San Francisco , Daniel Lucey , Jeffrey Fennelly , Division Of Hematologic Oncology , National Cancer Institute , Member Of The Program In Molecular Pharmacology , Columbia University School Of Social Work , Women Research Initiative , Women Information Service , San Francisco General Hospital , Information Service , Well Project , Research Initiative , Columbia University School , Social Work , New York City , Wall Street Journal , Respect For All Liaison , West Side High School , Youth Education Life Line , Internal Medicine , Medical Oncology , Hematologic Oncology ,

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United States , Guenther Koehne , Miami Cancer Institute , Baptist Health , Marrow Transplant , Hematologic Oncology , Benign Hematology ,

Uproleselan Plus Chemotherapy Misses Phase 3 Trial OS End Point in R/R AML

Uproleselan plus chemotherapy did not achieve a statistically significant improvement in OS vs chemotherapy alone in patients with relapsed/refractory AML.

....

United States , Harout Semerjian , Chinese National Medical Products Administration , National Cancer Institute , Alliance For Clinical Trials In Oncology , Clinical Trials , Hematologic Oncology , Acute Myeloid Leukemia ,

AML, ALL, and Glioblastoma Multiforme Clinical Trials Seek to Push the Needle Forward

Leland Metheny, MD, discusses how agents such as Iomab-B have potential to shift practice in the hematologic malignancy space. ....

United States , Leland Metheny , Oncology Program At Case Comprehensive Cancer Center , University Hospitals Cleveland Medical Center , Case Western Reserve University School Of Medicine , Case Western Reserve University School , Immune Oncology Program , Case Comprehensive Cancer Center , Hematologic Oncology , Glioblastoma Multiforme ,